SARS-CoV-2 variants and vaccines

Philip R. Krause, Thomas R. Fleming, Ira M. Longini, Richard Peto, Sylvie Briand, David L. Heymann, Valerie Beral, Matthew D. Snape, Helen Rees, Alba Maria Ropero, Ran Balicer, Jakob P. Cramer, César Muñoz‑Fontela, Marion Gruber, Rogerio Gaspar, Jerome A. Singh, Kanta Subbarao, Maria D. van Kerkhove, Soumya Swaminathan, Michael J. RyanAna Maria Henao-Restrepo

Research output: Contribution to journalArticlepeer-review

271 Scopus citations


Viral variants of concern may emerge with dangerous resistance to the immunity generated by the current vaccines to prevent coronavirus disease 2019 (Covid-19). Moreover, if some variants of concern have increased transmissibility or virulence, the importance of efficient public health measures and vaccination programs will increase. The global response must be both timely and science based.

Original languageEnglish
Pages (from-to)179-186
Number of pages8
JournalNew England Journal of Medicine
Issue number2
StatePublished - 8 Jul 2021
Externally publishedYes

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'SARS-CoV-2 variants and vaccines'. Together they form a unique fingerprint.

Cite this